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Abstract
Chronic rhinosinusitis is divided into nasal polyp subtype and non-nasal polyp subtype.
Among those subtypes, there are different histopathologic patterns. One of the criteria
of the histopathological parameter is inflammatory cells pattern in sinonasal tissue
which can be assessed by counting lymphocytes in sinonasal tissue. This study aims to
describe the representation of lymphocytes in sinonasal tissue of chronic rhinosinusitis
patients. This descriptive observational study included 21 chronic rhinosinusitis patients
in otolaryngology clinic of Dr. Sardjito Hospital Yogyakarta, Indonesia who had
undergone endoscopic sinus surgery during the year 2013 and fulfilled the criteria.
Information about sample subtypes was obtained from medical record while data about
lymphocytes count in sinonasal tissue was obtained from counting microscopically
using the light microscope in 5 zigzag consecutive high-power fields (HPF). Nasal
polyp subtype was found in 20 (95.24 %) cases while nonnasal polyp subtype was
in 1 case (4.76 %). Representation of lymphocytes in nasal polyp subtype was higher
than that in non-nasal polyp subtype. Mean, standard deviation, median, minimum
count, and maximum count of tissue lymphocyte in nasal polyp subtype were 78
cells/HPF, 46 cells/HPF, 65 cells/HPF, 25 cells/HPF, and 207 cells/HPF respectively
while tissue lymphocyte count in non-nasal polyp subtype was 21 cells/HPF. Using
Hellquist classification, the histopathological characteristics of nasal polyp subtype
were described. The highest count of tissue lymphocytes was found in Hellquist
type IV. Within one disease entity, two subtypes, and four histological types, chronic
rhinosinusitis has a highly variable amount of tissue lymphocytes.
Keywords: Chronic rhinosinusitis, Histopathology, Lymphocyte(s), Nasal polyps,
Hellquist classification.
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1. Introduction
Chronic rhinosinusitis is chronic inflammation of nasal mucosa and paranasal sinus(es)
for at least 12 consecutive weeks. It commonly occurs in adult and elderly age, particu-
larly within 30 yr to 69 yr. Its prevalence increases with age. Women experience chronic
rhinosinusitis more often than men [1].
The prevalence of chronic rhinosinusitis in the global population is estimated as much
as 14 % [2]. In the United States, based on data of the 2012 National Health Interview
Survey (NHIS), 12.1 % of the total population was diagnosed with rhinosinusitis [3]. Data
from 2013 Ministry of Health of Republic Indonesia showed that the disease was in
25𝑡ℎ place of first 50 most common disease patterns or around 102 817 outpatients in
hospital [4, 5]. During January to August 2005, asmany as 300 of 450 rhinologic patients
(69 %) was diagnosed with chronic rhinosinusitis in Rhinologic Division of ENT Depart-
ment Ciptomangunkusumo Hospital Jakarta, Indonesia. In Hasan Sadikin Hospital Ban-
dung, Indonesia during January to December 2007 there were 168 chronic rhinosinusitis
patients (64.29% of all rhinologic patients) [6]. In Dr. Sardjito Central Hospital Yogyakarta,
Indonesia during 2000 to 2006, the frequency of chronic rhinosinusitis patients was 2.5
% to 4.6 % [7] while during 2006–2007 there were 118 chronic rhinosinusitis patients (42
% of all rhinologic patients) [6].
Pathogenesis of chronic rhinosinusitis is a chronic inflammation with polyfactorial
causes. The underlying process is an alteration in many spectrums such as histopathol-
ogy, inflammatory cells pattern and T-cell, remodeling, eicosanoid and IgE produc-
tion, microorganism, and epithelial barrier malfunction [8]. The pathologic process of
paranasal sinuses in chronic rhinosinusitis results from long-term inflammation process
of nasal and sinusal mucoperiosteum layer and is the continuity of acute inflammation.
Theoretically, the long-running pathologic process of mucosa may result in proliferation,
granulation tissue formation, or granulomatous inflammation in the sinusal mucosa
which in turn develop into sinusal mucosa thickening [9].
Based on the endoscopic finding, chronic rhinosinusitis may be accompanied by a
nasal polyp or not. Histopathologically, chronic rhinosinusitis with nasal polyp is known
to have eosinophilic inflammation pattern despite the existence of non-eosinophilic vari-
ation, with plasma cell number proportional to polyp degree. Chronic rhinosinusitis with-
out nasal polyp is known to have neutrophilic inflammation pattern although the study by
Polzehl et al., demonstrated that neutrophil number in nasal polyp and nonnasal polyp
chronic rhinosinusitis is not significantly distinctive [10]. However, lymphocyte involve-
ment in chronic rhinosinusitis pathology was not assessed in that study.
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Lymphocyte infiltration in nasal and paranasal sinusalmucosa is one of the histopatho-
logical signs of chronic inflammation in chronic rhinosinusitis. This findingmay have both
prognostic value to long-term clinical outcome and predictive value to the persistence of
disturbing symptoms after application of definitive therapy sinus endoscopic surgery [11].
Furthermore, representation of lymphocyte number which depicts its distribution may
show inflammation pattern in chronic rhinosinusitis. The pattern may affect the disease
prognosis, asthma comorbidity, surgical approach, recurrence, and pharmacological
management [8].
2. Materials and Methods
2.1. Materials
The sinonasal tissue sample was obtained during an endoscopic procedure. Then it
was processed into preparations on an object glass size (75 × 25 × 1) mm, fixated
and preserved with 10 % formalin, stained with Hematoxylin-Eosin, and covered with a
(22 × 22 × 0.16) mm cover glass. Tissue lymphocyte was counted on preparations which
observed using a binocular light microscope. Data of chronic rhinosinusitis subtype
(with or without polyp) were obtained from medical record of patients who undergo the
endoscopic procedure.
2.2. Methods
This research was a descriptive observational study which involved rhinosinusitis
patients of ENT-HN polyclinic in Dr. Sardjito Central Hospital Yogyakarta during January
to December 2013. Diagnosis of rhinosinusitis was based on Task Force criteria as
follows experienced symptoms for 12 wk or more duration, diagnosed with a nasal
polyp or non-nasal polyp chronic rhinosinusitis based on the endoscopic finding, had
undergone endoscopic surgery to obtain a sinonasal tissue sample, and agree to
participate as the subject of study. Patients were excluded from the study if having
sinonasal and leukocyte malignancy and incomplete medical record. Lymphocyte count
was done in five randomly selected consecutive high-power fields in the zigzag direction
in sinonasal tissue preparations using a light microscope with 400 times magnification
then the average number was calculated to obtain lymphocyte count per high power
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field (HPF). Histopathological observation and tissue lymphocyte counting were per-
formed subjectively by the first author and another undergraduate student to ensure
the validity.
2.3. Data analysis
Descriptive analysis was carried out using IBMSPSSStatistics 22𝑛𝑑 version forWindows®
Operating System. Categorical data of chronic rhinosinusitis subtype were presented in
percentage to the number of the sample which then showed the proportion of nasal
polyp and nonnasal polyp chronic rhinosinusitis patients. Numerical data of tissue lym-
phocyte average number per HPF were presented in mean, deviation standard, median
number, minimum number, maximum number, then further group based on its subtype.
In each subtype group, mean, deviation standard, median number, minimum number,
and maximum number were calculated.
3. Results
Twenty-one chronic rhinosinusitis patients met the criteria consisted of 20 cases
(95.24 %) of chronic rhinosinusitis with nasal polyp and one case of chronic rhinosinusitis
without nasal polyp were included (Fig. 1). Among chronic rhinosinusitis with nasal polyp
cases, there were two cases of inverted papilloma. Histological appearance of chronic
rhinosinusitis with a nasal polyp, without nasal polyp, and inverted papilloma is shown
in Fig. 2.
An average number of lymphocyte in preparations was 76 cells/HPF with devia-
tion standard of 47 cells/HPF. Lymphocyte count laid between 21 cells/HPF and 207
cells/HPF. Lymphocyte median number was 60 cells/HPF. Its distribution in chronic
rhinosinusitis tissue preparations can be seen in Fig. 3 where lymphocytes mostly were
found in lamina propria and rarely in the epithelium. Tissue lymphocytes count of both
nasal polyp and nonnasal polyp group is summarized in Table 1.
Table 1: Descriptive analysis of tissue lymphocytes count in chronic rhinosinusitis.
Subtype n (%) Mean SD Median Min Max
Non-polyp 1 (4.76 %) 21.20 - 21.20 21.20 21.20
Polyp 20 (95.24 %) 78.37 46.32 64.90 24.60 206.80
Total 21 (100.0 %) 75.65 46.83 60.20 21.20 206.80
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Figure 2: Histopathology of chronic rhinosinusitis sinonasal tissue (a) polyp, (b) nonpolyp, and (c) inverted
papilloma (H&E; 400×).
The nasal polyp group was further grouped based on the classification method
invented by Hellquist [12]. Grouping was performed based on histopathological charac-
teristics into edematous type (Hellquist I), fibroinflammatory type (Hellquist II), seromu-
cinous gland hyperplasia type (Hellquist III), and atypical stroma type (Hellquist IV). In
this study, there was one case of nasal polyp which was unable to be grouped based on
Hellquist classification because the observed tissue was adjacent skin tissue instead
of nasal mucosa tissue thus total nasal polyp cases included in Hellquist classification
were 19 cases. By subjective histopathological assessment, seven cases (36.8 %) were
grouped as Hellquist type I, seven cases (36.8 %) were Hellquist type II, three cases
(15.8 %) were Hellquist type III, and two cases (10.5 %) were Hellquist type IV (Fig. 4).
Histological appearance of each Hellquist types is shown in Fig. 5. The highest mean
of tissue lymphocytes count was found in Hellquist type IV, i.e. 170.8 cells/HPF, whereas
the lowest one, i.e. 55.06 cells /HPF found in Hellquist type I (Table 2).
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Hellquist I Hellquist II Hellquist III Hellquist IV
Figure 4: Histopathological types of nasal polyp in chronic rhinosinusitis.
Table 2: Tissue lymphocytes count in nasal polyp group of chronic rhinosinusitis.
Hellquist n (%) Mean SD Median Min Max
I 7 (36.8 %) 55.06 25.07 50.60 28.20 90.80
II 7 (36.8 %) 87.06 37.92 90.40 36.60 143.40
III 3 (15.8 %) 68.80 24.27 60.20 50.00 96.20
IV 2 (10.5 %) 170.80 50.91 134.80 134.80 206.80
Total 19 (100 %) 81.20 45.77 69.60 28.20 206.80
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Figure 5: Histopathology of nasal polyp in chronic rhinosinusitis based on Hellquist classification (a)
edematous type, (b) fibroinflammatory type, (c) seromucinous gland hyperplastic type, and (d) atypical
stroma type (H&E x400).
4. Discussion
Chronic inflammation in chronic rhinosinusitis is a secondary process resulting from
local immune dysfunction as a defect of epithelial barrier integrity and of inflammatory
response regulation to foreign antigen13 which may be precipitated by persistent stim-
ulus or dysregulation of endogenous anti-inflammation mechanism which in the normal
state manage to coordinate resolution [14].
Histologically, chronic inflammation correlates with the presence of lymphocytes,
macrophages, and also eosinophil and basophil in certain conditions, and blood vessel
proliferation, fibrosis, and tissue necrosis [15]. Activation of lymphocytes determines
which type of lymphocyte to be recruited as well as the type of inflammation to occur
along with a contribution from other inflammatory cells through cytokine-mediated cell
communication [16].
Lymphocyte dominance in 90.5 % chronic rhinosinusitis tissue preparation and
eosinophil cells dominance in the rest 9.5 % were found in subjective scanning of
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tissue inflammatory cells profile. This finding corresponded with chronic inflammation
characteristic [16].
One of the underlying mechanisms of difference in histopathological appearance is T-
helper cells population heterogeneity in which the subset dominationmay determine the
type of inflammation. Edematous appearance correlates with T-helper 2 cell-mediated
inflammatory environment. In that type of inflammation, expression of FoxP3 in T regu-
latory cell decreases which in turn causes reduction of tumor growth factor beta-1 (TGF-
β1) protein level and extracellular matrix destruction. Fibrosis appearance correlates with
adequate T-regulatory cell function which increases TGF- β1 protein level and causes
tissue collagen deposition.8
Chronic inflammation may manifest in rhinosinusitis as nasal polyp which served as
different phenotype from chronic rhinosinusitis without nasal polyp in endoscopic find-
ing. In this study, nasal polyp cases were 20 fold times nonnasal polyp case. It suggests
that patients receiving endoscopic surgical therapy were mostly those who had a nasal
polyp. Surgical therapy is indicated in cases failed to medication therapy or in cases
requiring extensive polyposis therapy [17]. Factors contributing to many surgical cases
coming from the nasal polyp group are a common failure of medication therapy and
persistent inflammation resulting from obstruction of ostiomeatal complex by the nasal
polyp.
This study showed that nasal polyp group had greater tissue lymphocytes average
count than a nonnasal polyp. However, the mean difference was not significant because
of the unequal sample size between 2 groups. Lymphocytes count in nasal polyp group
had large standard deviation which suggested very vast lymphocytes count within 1
group. Tissue lymphocytes count alone cannot be used to differentiate two phenotypes
of chronic rhinosinusitis because lymphocytes infiltration can always be found in tis-
sue with chronic inflammation. Also, it requires combination with other histopatholog-
ical signs such as other inflammatory cells count (eosinophils, neutrophils, mast cells,
macrophages, and plasma cells), the presence of basal membrane thickening, tissue
remodeling pattern (edematous or fibrosis), and bone structure alteration. Assessment
of lymphocytes differentiation using either immunohistochemistry or flow cytometry is
also necessary to elicit underlying inflammatory pattern because both phenotypes have
different inflammatory pattern even though other factors such as race may also play a
role.
A nasal polyp is a chronic inflammatory condition of nasal and paranasal sinusmucosa
membrane in the form of edematous mass raised from inflamed mucosa and forming
a stalked mass. Massive edematous characteristic in a nasal polyp is resulted from
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plasma leakage because of loose endothelial cells [18]. The nasal polyp can be further
classified based on various criteria in which one of them is Hellquist classification [17,
19]. The classification is based on morphological characteristics of histopathological
findings. Hellquist type I (eosinophilic or edematous polyp) has characteristics of ede-
matous stroma with many eosinophils and mast cells, goblet cells hyperplasia, and basal
membrane thickening. Hellquist type II (fibroinflammatory polyp) is characterized by
a distinct inflammatory infiltrate with lymphocytes predominance, without edematous
stroma nor goblet cells hyperplasia. Hellquist type III (polyp with seromucinous gland
hyperplasia) is characterized by the enormous amount of seromucinous gland and duct
structure in the edematous stroma. Hellquist type IV (polyp with atypical stroma) has
characteristic of the presence of bizarre and atypical stromal cells which appear irregular
and hyperchromatic.
Further histopathological classification of the nasal polyp was carried out in this study
because of the dominance of nasal polyp cases in the sample size. The classification
was based on the most relevant findings, which were the most dominant ones. Couto
et al. mentioned that more than one histological pattern might be present in 1 single
polyp which could lead to adequate sample characterization difficulty [17].
Hellquist type I cases were asmany as Hellquist type II cases and theywere themajor-
ity of the total cases, followed by Hellquist type III, then Hellquist type IV. Meanwhile, a
study done by Couto et al., in Brazil figured out that Hellquist type I was the majority
(65 cases, 73 %), followed by Hellquist type II (16 cases, 18 %), Hellquist type III (6 cases,
6.7 %), and Hellquist type IV (two cases, 2.3 %) [17]. Another study performed by Souza
et al., with a sample size of 17 cases unveiled that fibroinflammatory polyp has the most
number of cases (14 cases) followed by fibrotic polyp (2 cases), and polyp with gland
hyperplasia (one case) with no case of eosinophilic polyp [20]. These different findings
might be influenced by geographical difference such as race, medication behavior, and
therapy status at the time of biopsy. In the study carried out Souza et al., all patients were
known to be in either topical or systemic corticosteroid therapy at the time of biopsy [20]
while in the study carried out by Couto et al., patients were not on anymedication (topical
or systemic corticosteroid, antihistamine, anti-leukotriene, or antibiotics) for at least 30
d before the biopsy [17]. Meanwhile, in this study, patients’ ongoing therapy status was
unknown.
Hellquist type IV cases had the greatest number of the tissue lymphocyte average
count, but it was also diverse. There was a probability of overlapping number in this type
andHellquist type II because of the similar basic nature of both types (only differed by the
presence of atypical stroma in Hellquist type IV). On the other hand, this diversity might
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be the consequence of a few numbers of cases belong to this type. Tissue lymphocyte
count in Hellquist type II was allegedly correlated to fibroinflammatory characteristics
through the diversity was also substantial enough. In Hellquist type III, the small count
of tissue lymphocytes might result from the crowded stroma by the hyperplastic glands
which made lymphocytes were more rarely found in the stroma. Tissue lymphocytes
count in Hellquist type I showed that despite its highly variable count, tissue lymphocyte
count tended to be low in edematous stroma particularly in the presence of eosinophil
dominance.
Descriptive analysis (Table 2) showed the diverse lymphocyte count distribution in
each Hellquist nasal polyp type. It might happen because normalization to exclude
outliers was not performed which was secondary to small sample size.
Random selection of view field without considering abundant lymphocytes infiltra-
tion area might also contribute to influence the result because the scanty lymphocytes
infiltration area would make the small count. In this matter, view field selection in the
epithelial area above basal membrane (especially in hyperplastic epithelium) and stroma
would result in a relatively small number of lymphocytes because inflammatory cells
tended to infiltrate basal membrane and lamina propria. Kanai et al. in Lacroix et al.,
stated that topical steroid therapy was known to reduce lymphocytes number in nasal
polyp tissue [19]. Referring to previous statement, patients’ status therapy needs to be
considered to minimize diversity.
5. Conclusions
Among 21 chronic rhinosinusitis patients who underwent endoscopic surgery found 20
cases (95.24 %) were nasal polyp cases. Tissue lymphocytes count was highly variable
within either one disease entity, two subtypes, or 4 nasal polyp histopathological types.
The count in nasal polyp subtype was higher than that in non-nasal polyp subtype of
chronic rhinosinusitis patients. The highest count was found in Hellquist IV, then followed
by Hellquist II, Hellquist III, and Hellquist I.
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